Expert consensus on the medical treatment of chronic musculoskeletal pain (2018)
Guideline name: Expert consensus on the medical treatment of chronic musculoskeletal pain (2018)
Issued by: Pain physicians branch of Chinese medical association
Post date: December 30, 2018
Drugs are the cornerstone of the treatment of chronic musculoskeletal pain (CMP).By the Chinese medical doctor association pain physician branch, national clinical key specialty of couplet of sino-japanese pain specialist hospital medical and joint pain treatment improved quality control center of Beijing domestic expert seminar for many times, in reference to foreign latest guidelines, widely collect clinical evidence at the same time, combined with clinical experience and China’s national conditions, formulated the “chronic musculoskeletal pain medications expert consensus (2018), in order to regulate and promote domestic CMP drug treatment work.
Classification: medication for chronic musculoskeletal pain